Clinical Trial Update: Phase 2a EBA Trial of AZD5847 [Phase 2]

View source ↗

Summary

Phase 2a trial update for AZD5847 in tuberculosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AZD5847

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED